Chemistry of the Ansamycin Antibiotics (Q34129450)

31 July 2017

1 reference

title

Chemistry of the ansamycin antibiotics (English)

1 reference

31 July 2017

Chemistry of the Ansamycin Antibiotics (English)

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

14 October 2022

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A11155

14 March 2022

author name string

K. L. Rinehart

0 references

L. S. Shield

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A11155

14 March 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=11155

14 March 2022

publication date

1 January 1976

1 reference

full work available at URL

31 July 2017

http://link.springer.com/content/pdf/10.1007/978-3-7091-3262-3_3

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Fortschritte der Chemie organischer Naturstoffe

14 March 2022

published in

1 reference

31 July 2017

33

1 reference

31 July 2017

231-307

1 reference

RNA-dependent DNA polymerase in virions of RNA tumour viruses

31 July 2017

3

226

1209

D Baltimore

1970

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Preferential inhibition of the growth of virus-transformed cells in culture by rifazone-82, a new rifamycin derivative

14 March 2022

6

71

2520

J Bissel

1974

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Streptovaricins inhibit RNA dependent DNA polymerase present in an oncogenic RNA virus

14 March 2022

8

230

249

WW Brockman

1971

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifamycins: an insight into biological activity based on structural investigations

14 March 2022

9

87

409

M Brufani

1974

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

The X-ray analysis of the structure of rifamycin B

14 March 2022

11

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

The X-ray analysis of the structure of rifamycin Y

14 March 2022

12

23

508

M Brufani

1967

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

[The biogenesis of rifamycin S]

14 March 2022

13

56

2315

M Brufani

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Oximes of 3-formylrifamycin SV. Synthesis, antibacterial activity, and other biological properties

14 March 2022

21

17

396

R Cricchio

1974

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Geldanamycin, a new antibiotic

14 March 2022

22

23

442

C Deboer

1970

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Pharmacology and toxicology of rifamide

14 March 2022

24

8

126

V Dezulian

1966

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Mechanism of Action of Rifamazine, a Member of a New Class of (Dimeric) Rifamycins

14 March 2022

26

52

391

AM Fietta

1975

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

[Coordination of the 13C-NMR. spectrum of rifamycin S on the basis of selective uncoupling of protons]

14 March 2022

27

56

2377

H Fuhrer

1973

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

ANTIBACTERIAL ACTIVITY OF RIFAMYCINS

14 March 2022

Reverse transcriptase, the DNA polymerase of oncogenic RNA viruses

32

0 references

33

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

3-Cyclic amine derivatives of rifamycin: strong inhibitors of the DNA polymerase activity of RNA tumor viruses

14 October 2022

38

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Interaction of purified ribonucleic acid directed deoxyribonucleic acid polymerase of avian myeloblastosis virus and murine sarcoma-leukemia virus with a rifamycin SV derivative

14 October 2022

39

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Tolypomycin, a new antibiotic. VII. Assay method for tolypomycin Y

14 October 2022

44

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Tolypomycin, a new antibiotic. II. Production and preliminary identification of tolypomycin Y

14 October 2022

45

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Geldanamycin biosynthesis and carbon magnetic resonance

14 October 2022

47

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

The x-ray analysis of tolypomycinone tri-m-bromobenzoate

14 October 2022

51

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifamycin biosynthesis: further studies on origin of the ansa chain and chromophore

14 October 2022

52

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Tolypomycin, a new antibiotic. 3. Isolation and characterization of tolypomycin Y.

14 October 2022

55

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Understanding of rifamycin S. Reactions of the ansa-rings. Modifications of antibiotics. 8

14 October 2022

60

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

[Understanding of rifamycin S. Reactions of the quinoid nucleus. Modifications of antibiotics. 9]

14 October 2022

61

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Tumor inhibitors. 96. Novel maytansinoids. Structural interrelations and requirements for antileukemic activity

14 October 2022

62

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus

14 October 2022

63

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Maytanprine and maytanbutine, new antileukaemic ansa macrolides from Maytenus buchananii

14 October 2022

64

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Isolation and structure of rifamycin L and its biogenetic relationship with other rifamycins

14 October 2022

65

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Isolation of rifamycin SV from a mutant Streptomyces mediterranei strain

14 October 2022

66

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Biogenesis of rifamycins. The conversion of rifamycin B into rifamycin Y

14 October 2022

67

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

[On the configuration of rifamycin B and related rifamycins]

14 October 2022

68

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifomycin Y and its transformation products

14 October 2022

69

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifampin: a semisynthetic derivative of rifamycin--a prototype for the future

14 October 2022

70

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Distribution and excretion of rifamide in rats and dogs

14 October 2022

74

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifamycins. XLI. A new class of active semisynthetic rifamycins. N-substituted aminomethyl derivatives of rifamycin SV 2

14 October 2022

77

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifampicin: A New Orally Active Rifamycin

14 October 2022

80

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Acetyl migration in rifampicin

14 October 2022

81

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Desacetyl-rifamycins: preparation and antibacterial properties

14 October 2022

82

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

[The constitution and configuration of rifamycins B, O, S and SV]

14 October 2022

94

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

The composition of rifamycin B and related rifamycins

14 October 2022

95

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Ansamycine, eine neuartige Klasse von mikrobiellen Stoffwechselprodukten

14 October 2022

99

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Structure-activity correlations among rifamycin B amides and hydrazides.

14 October 2022

100

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Relative biological activities of individual streptovaricins and streptovaricin acetates.

14 October 2022

104

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Field desorption mass spectra of antibiotics

14 October 2022

105

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Letter: Atropisomeric streptovaricins

14 October 2022

107

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Chemistry of the streptovaricins. 8. Structures of streptovaricins A, B, D, E, F, and G

14 October 2022

109

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifamycins: a general view

14 October 2022

113

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifomycin IX. Two new antibiotics of rifomycin family: rifomycin S and rifomycin SV. Preliminary report

14 October 2022

126

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

RIFAMYCINS. XXXV. AMIDES AND HYDRAZIDES OF RIFAMYCIN B3

14 October 2022

129

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifomycin IX. Two new antibiotics of rifomycin family: rifomycin S and rifomycin SV. Preliminary report

14 October 2022

132

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

TOLYPOMYCIN, A NEW ANTIBIOTIC. I

14 October 2022

133

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Agents which inhibit reverse transcriptases

14 October 2022

135

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Viral RNA-dependent DNA Polymerase: RNA-dependent DNA Polymerase in Virions of Rous Sarcoma Virus

14 October 2022

140

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

A proposal for the transfer of Streptomyces mediterranei margalith and beretta 1960 to the genus Nocardia as Nocardia mediterranea (margalith and beretta) Comb. Nov

14 October 2022

141

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Detergent effects on a reverse transcriptase activity and on inhibition by rifamycin derivatives.

14 October 2022

143

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Inhibition of three nucleotide polymerases by rifamycin derivatives

14 October 2022

144

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Synthesis of some rifamycin derivatives as inhibitors of an RNA-instructed DNA polymerase function

14 October 2022

150

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifamycin derivatives as inhibitors of a ribonucleic acid instructed deoxyribonucleic acid polymerase function. Effect of lipophilicity.

14 October 2022

151

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Plant antitumour agents: colubrinol acetate and colubrinol, antileukaemic ansa macrolides from Colubrina texensis

14 October 2022

155

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Interaction of rifamycin with bacterial RNA polymerase

14 October 2022

156

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Ansamycin biogenesis: incorporation of (1-13C)glucose and (1-13C)glycerate into the chromophore of rifamycin S

14 October 2022

160

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Rifamycin Biosynthesis Studied with 13C Enriched Precursors and Carbon Magnetic Resonance

14 October 2022

161

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Ansamycin biogenesis: studies on a novel rifamycin isolated from a mutant strain of Nocardia mediterranei

14 October 2022

162

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Naphthomycin, a novel ansa macrocyclic antimetabolite. Proton NMR spectra and structure elucidation using lanthanide shift reagent.

14 October 2022

164

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Initial studies on the cytotoxic action of maytansine, a novel ansa macrolide

14 October 2022

166

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

Biochemical mechanism of action of substance B-44-P

14 October 2022

167

1 reference

https://api.crossref.org/works/10.1007/978-3-7091-3262-3_3

14 October 2022

Identifiers

0 references

1 reference